COVID-19 and Global Chronic Disease 2025: New Challenges

Dear Colleagues,

Coronavirus disease 2019 (COVID-19) is the condition caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Since the COVID-19 pandemic in 2020, our perspectives on healthcare systems and research have changed. This crisis emphasized the connection between clinical practice, health policies and research. On 5 May 2023, the head of the World Health Organization declared “with great hope” an end to COVID-19 as a public health emergency. However, the end of the pandemic will not be the end of COVID-19. New SARS-CoV-2 variants are still being detected, and it is necessary to continue protecting the most vulnerable people against the disease and its complications. In this way, many pivotal points are open and need to be clarified by the scientific community, from bench to bedside.

Aim and Scope:

This Special Issue, titled “COVID-19 and Global Chronic Disease 2025: New Challenges”, aims at reporting the state of the art and the new challenges resulting from COVID-19. In particular, we would like to discuss and analyze diagnostic aspects, new therapies, public health policies and social aspects related to this condition and its complications. We invite worldwide eminent scholars and emerging researchers to submit high-scientific-level articles on the topics indicated by the keywords below.

Prof. Dr. Ludovico Abenavoli
Dr. Filippo Lococo
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diseases is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.